MILPITAS, Calif.--Applied StemCell, Inc. (ASC), a leading gene-editing company, announced that it has joined the National Institute of Standards and Technology (NIST) Genome Editing Consortium. Applied StemCell brings to the Consortium its expertise in TARGATT™ CRISPR/Cas9 gene-editing tools and induced pluripotent stem cell (iPSC) technology for the advancement of drug discovery and therapeutic applications. As part [...]

New gastrointestinal panel includes comprehensive viral coverage and provides Sample to Insight workflows to clinics in Europe and Australia Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European rollout of its next-generation QIAstat-Dx panel for one-step, fully integrated molecular analysis of gastrointestinal (GI) syndromes. The multiplex gastrointestinal panel, [...]

Cambridge, UK – Cresset, innovative provider of software and contract research services for small molecule discovery and design, and Elixir Software, provider of real-time workflow tracking applications, have formed an alliance whereby the combination of their technologies will form the basis of a new groundbreaking application, which will radically increase the efficiency of drug discovery by [...]

Hedera’s Next-generation Distributed Ledger Technology Moves Beyond Traditional Blockchain to Provide Certara with a Near Real-time, Public, Scalable Platform to Address Key Clinical Research, Regulatory Reporting and Supply Chain Challenges PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that it has formed a [...]

SEATTLE -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a new $100 million term loan facility with the CR Group L.P. (CRG), a health care focused investment firm. The proceeds of the initial draw under the CRG term loan facility, made in the aggregate [...]

The Government of Canada awards $50,000 in funding to this Montreal startup company MONTREAL / - Canada Economic Development for Quebec Regions (CED) David Lametti, Member of Parliament for LaSalle‒Émard‒Verdun and Parliamentary Secretary to the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for Canada Economic Development for Quebec Regions, announced that eNuvio, a highly innovative company, will receive $50,000 in funding, [...]

SCOTTSDALE, Ariz. -- PathogenDx, Inc., the innovative provider of DNA-based pathogen testing technology for the cannabis industry, announced today the release of the first quantitative microarray-based test for cannabis, PDx-Quant™, which can determine whether or not a sample exceeds a state or a federal regulatory agency's specific standards.  This one-stop microbial testing technology delivers a completely different level of [...]

BERGISCH GLADBACH, BIELEFELD - Miltenyi Biotec GmbH, a global provider of products and services for advancing biomedical research and cellular therapy, announced today that it has acquired the high-end microscopy specialist LaVision BioTec GmbH. Located in Bielefeld, Germany, LaVision BioTec is a leading global specialist for advanced light-sheet and multiphoton microscopy solutions for life science applications. [...]

Ulm, Germany – Sartorius Stedim Biotech held its topping-off ceremony for the new Cell Culture Technology Center at Science Park III located in the scientific hub of Ulm, Germany. This laboratory and office facility covering 6,000 square meters will approximately double the space available so far at Sartorius Stedim Biotech’s current site in Laupheim. With the [...]

Latest genome reference build offers enhanced interpretation results; improves clinical workflows and patient care, access to diverse population data OAKLAND, Calif.--Fabric Genomics™, a global leader in clinical interpretation of genomic data, announced today that it is offering select customers the option of using ‘Build 38,’ the most current reference genome assembly, for their clinical genetic [...]